nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—FGB—Hemostasis—MMP1—osteoarthritis	0.000577	0.000577	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.000573	0.000573	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—TIMP1—osteoarthritis	0.000573	0.000573	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00057	0.00057	CbGpPWpGaD
Sucralfate—FGF2—FRS2-mediated cascade—IL6—osteoarthritis	0.000569	0.000569	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TIMP1—osteoarthritis	0.000567	0.000567	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—MMP1—osteoarthritis	0.000565	0.000565	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—MMP1—osteoarthritis	0.000565	0.000565	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—MMP9—osteoarthritis	0.000565	0.000565	CbGpPWpGaD
Sucralfate—FGF2—Endochondral Ossification—TGFB1—osteoarthritis	0.00056	0.00056	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—MMP9—osteoarthritis	0.000553	0.000553	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—MMP9—osteoarthritis	0.000553	0.000553	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000547	0.000547	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.000546	0.000546	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—FN1—osteoarthritis	0.000542	0.000542	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—ESR1—osteoarthritis	0.00054	0.00054	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000537	0.000537	CbGpPWpGaD
Sucralfate—FGF2—Differentiation Pathway—IL6—osteoarthritis	0.000531	0.000531	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—COL9A2—osteoarthritis	0.00053	0.00053	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—FN1—osteoarthritis	0.000526	0.000526	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—IL1B—osteoarthritis	0.000526	0.000526	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000526	0.000526	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000526	0.000526	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—COL9A2—osteoarthritis	0.00052	0.00052	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—COL9A2—osteoarthritis	0.00052	0.00052	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—FN1—osteoarthritis	0.000516	0.000516	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—FN1—osteoarthritis	0.000516	0.000516	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—COL9A1—osteoarthritis	0.000515	0.000515	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HSPA5—osteoarthritis	0.000515	0.000515	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00051	0.00051	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—CRP—osteoarthritis	0.000505	0.000505	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—COL9A1—osteoarthritis	0.000505	0.000505	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—COL9A1—osteoarthritis	0.000505	0.000505	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFBI—osteoarthritis	0.000471	0.000471	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP3—osteoarthritis	0.00047	0.00047	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—TGFB1—osteoarthritis	0.000465	0.000465	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—IGF1—osteoarthritis	0.000461	0.000461	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—TGFB1—osteoarthritis	0.000456	0.000456	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—TGFB1—osteoarthritis	0.000456	0.000456	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—IGF1—osteoarthritis	0.000452	0.000452	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—IGF1—osteoarthritis	0.000452	0.000452	CbGpPWpGaD
Sucralfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.00045	0.00045	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00045	0.00045	CbGpPWpGaD
Sucralfate—FGF2—Disease—FMOD—osteoarthritis	0.000448	0.000448	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MCF2L—osteoarthritis	0.000442	0.000442	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IHH—osteoarthritis	0.000442	0.000442	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CTSK—osteoarthritis	0.000427	0.000427	CbGpPWpGaD
Sucralfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.00042	0.00042	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—CRP—osteoarthritis	0.000411	0.000411	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CTSK—osteoarthritis	0.00041	0.00041	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.000408	0.000408	CbGpPWpGaD
Sucralfate—EGF—Disease—GSTO1—osteoarthritis	0.000407	0.000407	CbGpPWpGaD
Sucralfate—FGF2—Disease—IHH—osteoarthritis	0.000399	0.000399	CbGpPWpGaD
Sucralfate—EGF—Disease—BGN—osteoarthritis	0.000394	0.000394	CbGpPWpGaD
Sucralfate—EGF—Immune System—CAMK2B—osteoarthritis	0.000393	0.000393	CbGpPWpGaD
Sucralfate—EGF—Immune System—CTSK—osteoarthritis	0.000393	0.000393	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000389	0.000389	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TNF—osteoarthritis	0.000381	0.000381	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP1—osteoarthritis	0.000376	0.000376	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000369	0.000369	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—MMP9—osteoarthritis	0.000361	0.000361	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—IL6—osteoarthritis	0.000354	0.000354	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—BMP2—osteoarthritis	0.000353	0.000353	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—MMP1—osteoarthritis	0.000353	0.000353	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—BMP2—osteoarthritis	0.000346	0.000346	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—BMP2—osteoarthritis	0.000346	0.000346	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000344	0.000344	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—FN1—osteoarthritis	0.000343	0.000343	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000339	0.000339	CbGpPWpGaD
Sucralfate—FGF2—IRS-mediated signalling—IL6—osteoarthritis	0.000336	0.000336	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—IL6—osteoarthritis	0.000333	0.000333	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000328	0.000328	CbGpPWpGaD
Sucralfate—FGF2—IRS-related events—IL6—osteoarthritis	0.000327	0.000327	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—CRP—osteoarthritis	0.000326	0.000326	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HSPA5—osteoarthritis	0.000326	0.000326	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—FN1—osteoarthritis	0.000325	0.000325	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—COL9A2—osteoarthritis	0.000324	0.000324	CbGpPWpGaD
Sucralfate—FGF2—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.000324	0.000324	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000323	0.000323	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—FN1—osteoarthritis	0.000322	0.000322	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—IL6—osteoarthritis	0.000318	0.000318	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—IL6—osteoarthritis	0.000317	0.000317	CbGpPWpGaD
Sucralfate—FGF2—Insulin receptor signalling cascade—IL6—osteoarthritis	0.000315	0.000315	CbGpPWpGaD
Sucralfate—FGF2—IGF1R signaling cascade—IL6—osteoarthritis	0.000315	0.000315	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—IL6—osteoarthritis	0.000315	0.000315	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—COL9A1—osteoarthritis	0.000315	0.000315	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL1B—osteoarthritis	0.000315	0.000315	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CRP—osteoarthritis	0.000314	0.000314	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—IL6—osteoarthritis	0.000314	0.000314	CbGpPWpGaD
Sucralfate—EGF—Immune System—HSPA5—osteoarthritis	0.000312	0.000312	CbGpPWpGaD
Sucralfate—FGA—Disease—SMAD3—osteoarthritis	0.00031	0.00031	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	0.000309	0.000309	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1RN—osteoarthritis	0.000304	0.000304	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFBI—osteoarthritis	0.000298	0.000298	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000295	0.000295	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—IL6—osteoarthritis	0.000295	0.000295	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—IL6—osteoarthritis	0.000295	0.000295	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—IL6—osteoarthritis	0.000293	0.000293	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP2—osteoarthritis	0.000291	0.000291	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.00029	0.00029	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—IL6—osteoarthritis	0.000289	0.000289	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—IGF1—osteoarthritis	0.000285	0.000285	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—IGF1—osteoarthritis	0.000282	0.000282	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MCF2L—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IHH—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TGFB1—osteoarthritis	0.000277	0.000277	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	0.000271	0.000271	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TGFB1—osteoarthritis	0.000271	0.000271	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TGFB1—osteoarthritis	0.000271	0.000271	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.000267	0.000267	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—IL6—osteoarthritis	0.000262	0.000262	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000261	0.000261	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—SMAD3—osteoarthritis	0.000258	0.000258	CbGpPWpGaD
Sucralfate—FGF2—Disease—GSTO1—osteoarthritis	0.000257	0.000257	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL1B—osteoarthritis	0.000256	0.000256	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000254	0.000254	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00025	0.00025	CbGpPWpGaD
Sucralfate—FGF2—Disease—BGN—osteoarthritis	0.000249	0.000249	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CTSK—osteoarthritis	0.000248	0.000248	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CAMK2B—osteoarthritis	0.000248	0.000248	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MMP3—osteoarthritis	0.000245	0.000245	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MMP3—osteoarthritis	0.00024	0.00024	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MMP3—osteoarthritis	0.00024	0.00024	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000233	0.000233	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	0.000228	0.000228	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—IL6—osteoarthritis	0.000224	0.000224	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SMAD3—osteoarthritis	0.000221	0.000221	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—LEP—osteoarthritis	0.00022	0.00022	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1A—osteoarthritis	0.000219	0.000219	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000219	0.000219	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP9—osteoarthritis	0.000218	0.000218	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000218	0.000218	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SMAD3—osteoarthritis	0.000217	0.000217	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SMAD3—osteoarthritis	0.000217	0.000217	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—BMP2—osteoarthritis	0.000216	0.000216	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000214	0.000214	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—IL6—osteoarthritis	0.000211	0.000211	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—COL9A2—osteoarthritis	0.000205	0.000205	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000203	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—IL6—osteoarthritis	0.000202	0.000202	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—IL6—osteoarthritis	0.000201	0.000201	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—IL6—osteoarthritis	0.000201	0.000201	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—IL6—osteoarthritis	0.0002	0.0002	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—COL9A1—osteoarthritis	0.000199	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CRP—osteoarthritis	0.000199	0.000199	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—IL6—osteoarthritis	0.000199	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HSPA5—osteoarthritis	0.000198	0.000198	CbGpPWpGaD
Sucralfate—EGF—Disease—SMAD3—osteoarthritis	0.000193	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1RN—osteoarthritis	0.000192	0.000192	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—LEP—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000187	0.000187	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—IL6—osteoarthritis	0.000187	0.000187	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—IL6—osteoarthritis	0.000187	0.000187	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—osteoarthritis	0.000186	0.000186	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—LEP—osteoarthritis	0.000185	0.000185	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—LEP—osteoarthritis	0.000185	0.000185	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—IL6—osteoarthritis	0.000185	0.000185	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	0.000184	0.000184	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000184	0.000184	CbGpPWpGaD
Sucralfate—EGF—Immune System—CRP—osteoarthritis	0.000183	0.000183	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—IL6—osteoarthritis	0.000183	0.000183	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—osteoarthritis	0.000181	0.000181	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ESR1—osteoarthritis	0.000181	0.000181	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—TGFB1—osteoarthritis	0.00018	0.00018	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FN1—osteoarthritis	0.000178	0.000178	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ESR1—osteoarthritis	0.000177	0.000177	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ESR1—osteoarthritis	0.000177	0.000177	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP2—osteoarthritis	0.000176	0.000176	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FN1—osteoarthritis	0.000175	0.000175	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FN1—osteoarthritis	0.000175	0.000175	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—TGFB1—osteoarthritis	0.000171	0.000171	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TGFB1—osteoarthritis	0.000169	0.000169	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000165	0.000165	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	0.000163	0.000163	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IGF1—osteoarthritis	0.000156	0.000156	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IGF1—osteoarthritis	0.000153	0.000153	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IGF1—osteoarthritis	0.000153	0.000153	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL6—osteoarthritis	0.00015	0.00015	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP3—osteoarthritis	0.00015	0.00015	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	0.000148	0.000148	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.000144	0.000144	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1A—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HSPA5—osteoarthritis	0.000137	0.000137	CbGpPWpGaD
Sucralfate—ALB—Metabolism—FMOD—osteoarthritis	0.000137	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—BMP2—osteoarthritis	0.000137	0.000137	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SMAD3—osteoarthritis	0.000135	0.000135	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP9—osteoarthritis	0.000132	0.000132	CbGpPWpGaD
Sucralfate—FGA—Disease—TGFB1—osteoarthritis	0.000131	0.000131	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TIMP1—osteoarthritis	0.000131	0.000131	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—IL6—osteoarthritis	0.000127	0.000127	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000126	0.000126	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCL8—osteoarthritis	0.000126	0.000126	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCL8—osteoarthritis	0.000123	0.000123	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCL8—osteoarthritis	0.000123	0.000123	CbGpPWpGaD
Sucralfate—FGF2—Disease—SMAD3—osteoarthritis	0.000122	0.000122	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	0.000119	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CRP—osteoarthritis	0.000116	0.000116	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—LEP—osteoarthritis	0.000116	0.000116	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IL6—osteoarthritis	0.000115	0.000115	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1B—osteoarthritis	0.000114	0.000114	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MMP9—osteoarthritis	0.000114	0.000114	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—osteoarthritis	0.000113	0.000113	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGES—osteoarthritis	0.000112	0.000112	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MMP9—osteoarthritis	0.000111	0.000111	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MMP9—osteoarthritis	0.000111	0.000111	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ESR1—osteoarthritis	0.00011	0.00011	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FN1—osteoarthritis	0.000109	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TGFB1—osteoarthritis	0.000109	0.000109	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—osteoarthritis	9.88e-05	9.88e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IGF1—osteoarthritis	9.56e-05	9.56e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP3—osteoarthritis	9.47e-05	9.47e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TGFB1—osteoarthritis	9.38e-05	9.38e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TGFB1—osteoarthritis	9.19e-05	9.19e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TGFB1—osteoarthritis	9.19e-05	9.19e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SMAD3—osteoarthritis	8.57e-05	8.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—osteoarthritis	8.22e-05	8.22e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—TGFB1—osteoarthritis	8.19e-05	8.19e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MMP1—osteoarthritis	8.14e-05	8.14e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTO1—osteoarthritis	7.86e-05	7.86e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL8—osteoarthritis	7.69e-05	7.69e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—BGN—osteoarthritis	7.61e-05	7.61e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	7.57e-05	7.57e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—FN1—osteoarthritis	7.43e-05	7.43e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—LEP—osteoarthritis	7.32e-05	7.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—osteoarthritis	7.26e-05	7.26e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1B—osteoarthritis	7.22e-05	7.22e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—osteoarthritis	7.17e-05	7.17e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—osteoarthritis	7.06e-05	7.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ESR1—osteoarthritis	6.99e-05	6.99e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP9—osteoarthritis	6.96e-05	6.96e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—osteoarthritis	6.92e-05	6.92e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—osteoarthritis	6.92e-05	6.92e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FN1—osteoarthritis	6.91e-05	6.91e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—osteoarthritis	6.68e-05	6.68e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IGF1—osteoarthritis	6.51e-05	6.51e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—osteoarthritis	6.17e-05	6.17e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IGF1—osteoarthritis	6.05e-05	6.05e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TGFB1—osteoarthritis	5.73e-05	5.73e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—TGFB1—osteoarthritis	5.18e-05	5.18e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	4.91e-05	4.91e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL8—osteoarthritis	4.87e-05	4.87e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP9—osteoarthritis	4.4e-05	4.4e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—osteoarthritis	4.32e-05	4.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—osteoarthritis	4.23e-05	4.23e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—osteoarthritis	3.9e-05	3.9e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB1—osteoarthritis	3.9e-05	3.9e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TGFB1—osteoarthritis	3.63e-05	3.63e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—osteoarthritis	2.73e-05	2.73e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—osteoarthritis	2.19e-05	2.19e-05	CbGpPWpGaD
